Alzheimer disease is an age-linked neurodegenerative disorder representing one of the greatest medical care challenges of our century. Several drugs are useful in ameliorating the symptoms, even if none could stop or reverse disease progression. The standard approach is represented by the cholinesterase inhibitors (ChEIs) that restore the levels of acetylcholine (ACh) by inhibiting the acetylcholinesterase (AChE). Still, their limited efficacy has prompted researchers to develop new ChEIs that could also reduce the oxidative stress by exhibiting antioxidant properties and by chelating the main metals involved in the disease. Recently, we developed some derivatives constituted by a 2-amino-pyrimidine or a 2-amino-pyridine moiety connected to various aromatic groups by a flexible amino-alkyl linker as new dual inhibitors of AChE and butyrylcholinesterase (BChE). Following our previous studies, in this work we explored the role of the flexible linker by replacing the amino group with an amide or a carbamic group. The most potent compounds showed higher selectivity against BChE in respect to AChE, proving also to possess a weak anti-aggregating activity toward A42 and tau and to be able to chelate Cu2+ and Fe3+ ions. Molecular docking and molecular dynamic studies proposed possible binding modes with the enzymes. It is noteworthy that these compounds were predicted as BBB-permeable and showed low cytotoxicity on the human brain cell line.

Design, synthesis, and In vitro, in silico and in cellulo evaluation of new Pyrimidine and Pyridine amide and Carbamate derivatives as multi-functional Cholinesterase Inhibitors / Bortolami, Martina; Pandolfi, Fabiana; Tudino, Valeria; Messore, Antonella; Madia, Valentina Noemi; De Vita, Daniela; Di Santo, Roberto; Costi, Roberta; Romeo, Isabella; Alcaro, Stefano; Colone, Marisa; Stringaro, Annarita; Espargaró, Alba; Sabatè, Raimon; Scipione, Luigi. - In: PHARMACEUTICALS. - ISSN 1424-8247. - 15:6(2022), pp. 1-31. [10.3390/ph15060673]

Design, synthesis, and In vitro, in silico and in cellulo evaluation of new Pyrimidine and Pyridine amide and Carbamate derivatives as multi-functional Cholinesterase Inhibitors

Bortolami, Martina;Pandolfi, Fabiana;Tudino, Valeria;Messore, Antonella;Madia, Valentina Noemi;De Vita, Daniela;Di Santo, Roberto;Costi, Roberta;Romeo, Isabella;Scipione, Luigi
2022

Abstract

Alzheimer disease is an age-linked neurodegenerative disorder representing one of the greatest medical care challenges of our century. Several drugs are useful in ameliorating the symptoms, even if none could stop or reverse disease progression. The standard approach is represented by the cholinesterase inhibitors (ChEIs) that restore the levels of acetylcholine (ACh) by inhibiting the acetylcholinesterase (AChE). Still, their limited efficacy has prompted researchers to develop new ChEIs that could also reduce the oxidative stress by exhibiting antioxidant properties and by chelating the main metals involved in the disease. Recently, we developed some derivatives constituted by a 2-amino-pyrimidine or a 2-amino-pyridine moiety connected to various aromatic groups by a flexible amino-alkyl linker as new dual inhibitors of AChE and butyrylcholinesterase (BChE). Following our previous studies, in this work we explored the role of the flexible linker by replacing the amino group with an amide or a carbamic group. The most potent compounds showed higher selectivity against BChE in respect to AChE, proving also to possess a weak anti-aggregating activity toward A42 and tau and to be able to chelate Cu2+ and Fe3+ ions. Molecular docking and molecular dynamic studies proposed possible binding modes with the enzymes. It is noteworthy that these compounds were predicted as BBB-permeable and showed low cytotoxicity on the human brain cell line.
acetylcholinesterase inhibitors; butyrylcholinesterase inhibitors; multifunctional compounds; amyloid aggregation; tau aggregation; metal chelation
01 Pubblicazione su rivista::01a Articolo in rivista
Design, synthesis, and In vitro, in silico and in cellulo evaluation of new Pyrimidine and Pyridine amide and Carbamate derivatives as multi-functional Cholinesterase Inhibitors / Bortolami, Martina; Pandolfi, Fabiana; Tudino, Valeria; Messore, Antonella; Madia, Valentina Noemi; De Vita, Daniela; Di Santo, Roberto; Costi, Roberta; Romeo, Isabella; Alcaro, Stefano; Colone, Marisa; Stringaro, Annarita; Espargaró, Alba; Sabatè, Raimon; Scipione, Luigi. - In: PHARMACEUTICALS. - ISSN 1424-8247. - 15:6(2022), pp. 1-31. [10.3390/ph15060673]
File allegati a questo prodotto
File Dimensione Formato  
Bortolami_Design-synthesis_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 870.6 kB
Formato Adobe PDF
870.6 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1638218
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact